Overall DYN gets a fundamental rating of 2 out of 10. We evaluated DYN against 525 industry peers in the Biotechnology industry. DYN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. DYN has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

In the past year DYN has reported negative net income.
DYN had a negative operating cash flow in the past year.
DYN had negative earnings in each of the past 5 years.
DYN had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

DYN's Return On Assets of -48.88% is in line compared to the rest of the industry. DYN outperforms 51.62% of its industry peers.
DYN has a better Return On Equity (-61.26%) than 61.14% of its industry peers.

		Industry Rank	Sector Rank
ROA	-48.88%
ROE	-61.26%
ROIC	N/A

ROA(3y)-81.24%

ROA(5y)-59.12%

ROE(3y)-125.15%

ROE(5y)-86.67%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for DYN so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

DYN has more shares outstanding than it did 1 year ago.
DYN has more shares outstanding than it did 5 years ago.
DYN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

DYN has an Altman-Z score of 6.07. This indicates that DYN is financially healthy and has little risk of bankruptcy at the moment.
DYN has a better Altman-Z score (6.07) than 75.05% of its industry peers.
A Debt/Equity ratio of 0.14 indicates that DYN is not too dependend on debt financing.
DYN has a worse Debt to Equity ratio (0.14) than 63.43% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.14
Debt/FCF	N/A
Altman-Z	6.07

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 13.47 indicates that DYN has no problem at all paying its short term obligations.
DYN has a better Current ratio (13.47) than 89.52% of its industry peers.
A Quick Ratio of 13.47 indicates that DYN has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 13.47, DYN belongs to the best of the industry, outperforming 89.71% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	13.47
Quick Ratio	13.47

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

DYN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -2.81%.

EPS 1Y (TTM)-2.81%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%20.83%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, DYN will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.62% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y-6.93%

EPS Next 2Y0.48%

EPS Next 3Y3.72%

EPS Next 5Y16.62%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DYN. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DYN. No positive earnings are expected for the next year.